Since hypoalbuminemia is frequently observed in clinical scenarios such as chronic liver disease, malnutrition, and severe inflammation [28,29,30,31,32], accurate model selection under abnormal albumin levels is critical to avoid dosing errors and ensure therapeutic efficacy. This evidence concerns the gene ALB and Hypoalbuminemia.